Mohs micrographic surgery: Facts and controversies

Clinics in Dermatology

Volumn 28, Issue 3, 2010, Pages 269-274

  Levy, Ross M ^a   Hanke, C William ^b  

^a NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

^b Laser and Skin Surgery Center of Indiana   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHEMOSURGERY; FROZEN SECTION; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MELANOMA; MERKEL CELL TUMOR; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; SURGICAL TECHNIQUE; TREATMENT INDICATION; TREATMENT OUTCOME; CARCINOMA, MERKEL CELL; CARCINOMA, SQUAMOUS CELL; CLINICAL PRACTICE; PROCEDURES; SKIN NEOPLASMS;

CARCINOMA, MERKEL CELL; CARCINOMA, SQUAMOUS CELL; HUMANS; MELANOMA; MOHS SURGERY; PHYSICIAN'S PRACTICE PATTERNS; SKIN NEOPLASMS;

EID: 77953569961     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clindermatol.2009.06.014     Document Type: Article

References (36)

1. Zitelli J.A., Brown CD Hanusa B.H. Surgical margins for excision of primary cutaneous melanoma. J Am Acad Dermatol 1997, 37:422-429.
2. Mohs F. Chemosurgical treatment of melanoma: a microscopically controlled method of excision. AMA Arch Dermatol Syphilol 1950, 62:269-279.
3. Mohs F.E., Snow SN Larson P.O. Mohs micrographic surgery fixed-tissue technique for melanoma of the nose. J Dermatol Surg Oncol 1990, 16:1111-1120.
4. Zitelli J.A., Moy RL Abell E. The reliability of frozen sections in the evaluation of surgical margins for melanoma. J Am Acad Dermatol 1991, 24:102-106.
5. Barlow R.J., White C.R., Swanson N.A Mohs' micrographic surgery using frozen sections alone may be unsuitable for detecting single atypical melanocytes at the margins of melanoma in situ. Br J Dermatol 2002, 146:290-294.
6. Zalla M.J., Lim K.K., Dicaudo D.J., et al. Mohs micrographic excision of melanoma using immunostains. Dermatol Surg 2000, 26:771-784.
7. Huilgol S.C., Selva D., Chen C., et al. Surgical margins for lentigo maligna and lentigo maligna melanoma: the technique of mapped serial excision. Arch Dermatol 2004, 140:1087-1092.
8. Dhawan S.S., Wolf D.J., Rabinovitz H.S., et al. Lentigo maligna. The use of rush permanent sections in therapy. Arch Dermatol 1990, 126:928-930.
9. Clayton B.D., Leshin B., Hitchcock M.G., et al. Utility of rush paraffin-embedded tangential sections in the management of cutaneous neoplasms. Dermatol Surg 2000, 26:671-678.
10. Walling H.W., Scupham R.K., Bean A.K., et al. Staged excision versus Mohs micrographic surgery for lentigo maligna and lentigo maligna melanoma. J Am Acad Dermatol 2007, 57:659-664.
11. Mallipeddi R.S.J., Xie X.J., Matthews M., Taylor R.S. A novel 2-Hour method for rapid preparation of permanent paraffin sections when treating melanoma in situ with mohs micrographic surgery. Dermatol Surg 2008, 34:1520-1526.
12. Naylor M.F., Crowson N., Kuwahara R., et al. Treatment of lentigo maligna with topical imiquimod. Br J Dermatol 2003, 149(Suppl 66):66-70.
13. Mahoney M.H., Joseph M.G., Temple C Topical imiquimod therapy for lentigo maligna. Ann Plast Surg 2008, 61:419-424.
14. McKenna J.K., Florell S.R., Goldman G.D., et al. Lentigo maligna/lentigo maligna melanoma: current state of diagnosis and treatment. Dermatol Surg 2006, 32:493-504.
15. Fisher G.H., Lang P.G. Treatment of melanoma in situ on sun-damaged skin with topical 5% imiquimod cream complicated by the development of invasive disease. Arch Dermatol 2003, 139:945-947.
16. Cotter M.A., McKenna J.K., Bowen G.M. Treatment of lentigo maligna with imiquimod before staged excision. Dermatol Surg 2008, 34:147-151.
17. Han A., Ratner D. What is the role of adjuvant radiotherapy in the treatment of cutaneous squamous cell carcinoma with perineural invasion?. Cancer 2007, 109:1053-1059.
18. Goepfert H., Dichtel W.J., Medina J.E., et al. Perineural invasion in squamous cell skin carcinoma of the head and neck. Am J Surg 1984, 148:542-547.
19. Mendenhall W.M., Parsons J.T., Mendenhall N.P., et al. Carcinoma of the skin of the head and neck with perineural invasion. Head Neck 1989, 11:301-308.
20. Rowe D.E., Carroll R.J., Day C.L. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection. J Am Acad Dermatol 1992, 26:976-990.
21. Leibovitch I., Huilgol S.C., Selva D., et al. Basal cell carcinoma treated with Mohs surgery in Australia II. Outcome at 5-year follow-up. J Am Acad Dermatol 2005, 53:452-457.
22. Osguthorpe J.D., Abel C.G., Lang P., et al. Neurotropic cutaneous tumors of the head and neck. Arch Otolaryngol Head Neck Surg 1997, 123:871-876.
23. Bichakjian C.K., Lowe L., Lao C.D., et al. Merkel cell carcinoma: critical review with guidelines for multidisciplinary management. Cancer 2007, 110:1-12.
24. Boyer J.D., Zitelli J.A., Brodland D.G., et al. Local control of primary Merkel cell carcinoma: review of 45 cases treated with Mohs micrographic surgery with and without adjuvant radiation. J Am Acad Dermatol 2002, 47:885-892.
25. O'Connor W.J., Roenigk R.K., Brodland D.G. Merkel cell carcinoma. Comparison of Mohs micrographic surgery and wide excision in eighty-six patients. Dermatol Surg 1997, 23:929-933.
26. Allen P.J., Bowne W.B., Jaques D.P., et al. Merkel cell carcinoma: prognosis and treatment of patients from a single institution. J Clin Oncol 2005, 23:2300-2309.
27. Medina-Franco H., Urist M.M., Fiveash J., et al. Multimodality treatment of Merkel cell carcinoma: case series and literature review of 1024 cases. Ann Surg Oncol 2001, 8:204-208.
28. Veness M.J. Merkel cell carcinoma: improved outcome with the addition of adjuvant therapy. J Clin Oncol 2005, 23:7235-7236. [author reply 7-8].
29. Wilson L.D., Gruber S.B. Merkel cell carcinoma and the controversial role of adjuvant radiation therapy: clinical choices in the absence of statistical evidence. J Am Acad Dermatol 2004, 50:435-437. [discussion 7-8].
30. Yiengpruksawan A., Coit D.G., Thaler H.T., et al. Merkel cell carcinoma. Prognosis and management. Arch Surg 1991, 126:1514-1519.
31. Todd M., Lee J.W., Marks V.J. Rapid Toluidine Blue Stain for Mohs' Micrographic Surgery. Dermatol Surg 2005, 31:241-245.
32. Humphreys T.R., Nemeth A., McCrevey S., et al. A pilot study comparing toluidine blue and hematoxylin and eosin staining of basal cell and squamous cell carcinoma during Mohs surgery. Dermatol Surg 1996, 22:693-697.
33. Silapunt S., Peterson S.R., Alcalay J., et al. Mohs tissue mapping and processing: a survey study. Dermatol Surg 2003, 29:1109-1112. [discussion 12].
34. Thosani M.K., Marghoob A., Chen C.S. Current progress of immunostains in Mohs micrographic surgery: a review. Dermatol Surg 2008, 34:1621-1636.
35. Bhardwaj S.S., Tope W.D., Lee P.K. Mohs micrographic surgery for lentigo maligna and lentigo maligna melanoma using Mel-5 immunostaining. University of Minnesota experience. Dermatol Surg 2006, 32:690-696. [discussion 6-7].
36. Hanke C.W., Leonard A.L., Reed A.J. Rapid preparation of high-quality frozen sections using a membrane and vacuum system embedding machine. Dermatol Surg 2008, 34:20-25.